Drawing for BETTER CELLS. BETTER LIVES.

USPTO serial 88167431

BETTER CELLS. BETTER LIVES.

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PINO, DOMINIC ROBERT
Law office
TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with BETTER CELLS. BETTER LIVES.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ernest V. Linek

Ernest V. Linek Banner Witcoff28 State StreetSuite 1800Boston, MA 02109

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations in the nature of stem cells solutions to enable stem cell expansion for therapeutic purposes, used in hematopoietic (blood) stem cell transplantation (HSCT) for patients with blood cancers; bioengineering pharmaceutical solutions containing small molecules for use in expanding cells for therapeutic use to patients with blood cancers and other diseasesACTIVE—
042Medical and scientific research in the field of stem cells; medical laboratory research; medical and scientific research namely, conducting pre-clinical and clinical trials for othersACTIVE—
044Medical procedures, namely hematopoietic (blood) stem cell transplantation (HSCT) for patients with blood cancersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 2, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 2, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 6, 2020ALIEASSIGNED TO LIE—
Sep 7, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 7, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Sep 7, 2019CNSLSUSPENSION LETTER WRITTEN—
Aug 9, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 9, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2019DOCKASSIGNED TO EXAMINER—
Nov 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 27, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance